Today: 29 April 2026
Browse Category

NASDAQ:RGC 25 September 2025 - 7 October 2025

No-Revenue Biotech Soars 64,000% – Is Regencell (RGC) a Breakthrough or a Bubble?

No-Revenue Biotech Soars 64,000% – Is Regencell (RGC) a Breakthrough or a Bubble?

Regencell Bioscience shares soared over 64,000% in 2025, peaking at $83.60 before plunging 74% to around $17–18 by October, with a market cap near $8.5 billion. The stock jumped again in early October after S&P Global BMI Index inclusion and positive Phase II trial data showing a 37% improvement in ADHD/ASD symptoms. Regencell remains unprofitable with no revenue. Analysts maintain a “Strong Sell” rating.
7 October 2025
··
Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

Regencell Bioscience (RGC) stock soared over 82,000% in 2025, peaking at $83.60 before plunging 74% after a 38-for-1 stock split and speculative trading frenzy. The Hong Kong biotech, which has no revenue and focuses on Traditional Chinese Medicine for neurocognitive disorders, now trades near $17 with an $8.5 billion market cap. Regulators halted trading multiple times amid extreme volatility.
4 October 2025
·
RGC Stock Skyrockets 11,000% – Inside Regencell Bioscience’s Wild 2025 Ride

RGC Stock Skyrockets 11,000% – Inside Regencell Bioscience’s Wild 2025 Ride

Regencell Bioscience (RGC) shares closed at about $14.50 on September 25, 2025, up over 10,000% year-to-date despite no approved products or revenues. The company, valued at $7.3 billion, remains pre-revenue and posted a $4.4 million loss in 2024. RGC’s stock saw a 38-for-1 split in June and is controlled mostly by insiders, with only 30.5 million shares publicly traded. The stock’s surge has drawn regulatory scrutiny over volatility and market manipulation risks.
25 September 2025
·
1 2

Stock Market Today

  • VTI Falls 0.3% as PLTR Stock Declines Amid Heavy Insider Selling
    April 29, 2026, 2:24 PM EDT. VTI, the Vanguard Total Stock Market ETF, dropped 0.3% today, weighed down by a 3.4% decline in Palantir Technologies (PLTR) shares. Notable VTI holdings like Nvidia (-1.2%), Microsoft (-1.2%), and Apple (-0.8%) also contributed to losses. PLTR insiders have sold 227 times in six months without any purchases, including major sales by Peter Thiel and CEO Alexander Karp, signaling potential negative sentiment. Despite recent analyst buy ratings from Mizuho, Citigroup, and others, RBC Capital issued an underperform rating. Investors can monitor PLTR's insider activity and analyst outlook via Quiver Quantitative's dashboards. The median PLTR price target remains incomplete in reports, further highlighting investor uncertainty.

Latest article

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

29 April 2026
Rising Dragon Acquisition Corp. shares surged over 400% to $21.72 Wednesday after the SPAC proposed extending its merger deadline with HZJL Cayman Limited. The company called a May 28 shareholder meeting to vote on extending the deadline by up to 15 months. Rising Dragon’s board urged shareholders to approve the extension. The HZJL merger has not closed.
Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

29 April 2026
Upstart Holdings shares fell $2.09 to $30.77 Wednesday after announcing Fortress Investment Group affiliates will buy up to $1.25 billion in consumer loans over 15 months. March loan originations rose 60% year over year to $1.263 billion. In 2025, Upstart’s revenue climbed 64% to $1.0 billion, with net income of $53.6 million after a $129 million loss in 2024. Upstart plans to apply for a national bank charter.
Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

29 April 2026
Intel shares surged 10% Wednesday after reports that Google may use Intel’s EMIB chip-packaging technology in its next AI processor. The stock hit $94.03 before settling at $93.23. Intel recently reported first-quarter revenue of $13.6 billion, up 7% year over year. CFO David Zinsner said some gains came from selling previously shelved chips.
Go toTop